Steve Wigginton, CEO of Icario, is responsible for the overall strategy, growth, and operations of the company. Previously the CEO of NovuHealth, Steve became the CEO of Icario in 2020 fol-lowing NovuHealth’s merger with Revel. Steve has a 25-year track record of driving growth, cul-ture, and innovation in healthcare and is passionate about creating a better experience for mem-bers, patients, and providers.
Steve came to Icario from Sutter Health | Aetna, a 50/50 joint venture between Aetna, a CVS Health company, and Sutter Health, a not-for-profit integrated health delivery system in northern California. There, he served as the joint venture’s first CEO, responsible for launching an innova-tive health insurance business, delivering best-in-class clinical care, and driving breakthrough consumer and member experiences.Before that, Steve served as CEO of Valence Health, where he led and grew the business following its acquisition by Evolent Health, doubling reve-nues and scaling operations internationally. Prior to the Valence acquisition, Steve was the chief development officer at Evolent Health, responsible for driving growth, partnerships, and the brand. Additional leadership roles in technology-driven care management, physician practice management, and healthcare supply chain businesses round out Steve’s experience.
Steve holds a bachelor’s and master’s degree of business administration from Indiana Universi-ty, Kelley School of Business. In his free time, Steve is an avid cyclist, traveler, and concertgoer. He and his wife, an award-winning OB/Gyn, have four beautiful children.
The health system will enter a new reality with the public health emergency lifted After several renewals, most expect the Covid-19 public health emergency (PHE) to be lifted in 2023, which has huge implications for health plans and members. Medicaid/CHIP enrollment has grown by 18.2 million since the onset of the pandemic in February 2020. […]
Considering these six forces at play will not only create an inherent competitive advantage, but it will also – more importantly – get populations to take health action and ultimately drive improved outcomes.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
One way MA plans can stand out in an increasingly competitive market is by making members aware of the benefits they may not even know they have and encouraging them to use those benefits.
Medicare and Medicaid plans that invest in effectively addressing these five health equity issues can create a win-win situation that both improves member satisfaction and retention
With Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey measures quadruple-weighted for contract year 2021, accounting for 32% of plans' overall Star Rating, the stakes for delivering member experiences that drive satisfaction are high.